Pharmaco - Press Releases

Date	Title	Company
13-Jun-2020	Designer Biosensors to Probe the Activation of Important Drug Targets - Research by Prof Arun Shukla, Department of BSBE, IIT Kanpur	Indian Institute Of Technology Kanpur
13-Jun-2020	Halozyme Announces Findings From Janssen's Phase 3 Andromeda Study Evaluating Subcutaneous Daratumumab Utilizing ENHANZE® In Light-Chain Amyloidosis Presented At European Hematology Association 25th Annual Congress	Halozyme Therapeutics, Inc.
13-Jun-2020	VENCLEXTA®/VENCLYXTO® (venetoclax) Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve Acute Myeloid Leukemia Patients	AbbVie
13-Jun-2020	EHA25Virtual: Study of Subcutaneous Daratumumab Shows Improved Clinical Outcomes in the Treatment of Patients with Amyloidosis	European Hematology Association (EHA)
13-Jun-2020	EHA25Virtual: A Paradigm Shift for the Treatment of Newly Diagnosed Older Acute Myeloid Leukemia Patients	European Hematology Association (EHA)
12-Jun-2020	Coronavirus (COVID-19) Update: Daily Roundup	U.S. Food and Drug Administration
12-Jun-2020	PANTHERx® Chosen as Exclusive Rare Pharmacy Partner by Viela Bio, Inc. for Uplizna(TM) (inebilizumab-cdon) for Adult Patients with AQP4+ Neuromyelitis Optica Spectrum Disorder (NMOSD)	PANTHERx Rare Pharmacy
12-Jun-2020	Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation	Mydecine Innovations Group Inc.
12-Jun-2020	RHÖN-KLINIKUM Aktiengesellschaft: Advanced negotiations on termination of the employment contract of the Chairman of the Management Board	RHÖN-KLINIKUM Aktiengesellschaft
12-Jun-2020	BiondVax Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update	BiondVax Pharmaceuticals Ltd.
12-Jun-2020	Tolero Pharmaceuticals Presents Findings from Phase 1 Zella 101 Clinical Study Evaluating Investigational Agent Alvocidib in Patients with Newly Diagnosed Acute Myeloid Leukemia at Virtual EHA Annual Congress 2020	Tolero Pharmaceuticals, Inc.
12-Jun-2020	I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II	I-Mab
12-Jun-2020	ZZ Biotech Announces FDA Fast Track Designation for Stroke Program	B3C newswire
12-Jun-2020	EHA25Virtual: Gut Microbiome Disturbance by Antibiotic Treatment Early in Life is Sufficient to Induce Leukemia in Predisposed Mice	European Hematology Association (EHA)
12-Jun-2020	EHA25Virtual: Ruxolitinib, the First Proven Drug for Treating Steroid-refractory Acute GVHD	European Hematology Association (EHA)
12-Jun-2020	EHA25Virtual: A Safe and Strikingly Effective Biologic Therapy for the World's Second Most Common Hereditary Bleeding Disorder	European Hematology Association (EHA)
12-Jun-2020	EHA25Virtual: Pegcetacoplan, a Novel C3 Complement Inhibitor - Beginning of a new era in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)	European Hematology Association (EHA)
12-Jun-2020	Avidity Biosciences Announces Pricing of Initial Public Offering	Avidity Biosciences, Inc.
11-Jun-2020	Leap Therapeutics Announces Oprhan Drug Designation of DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer	Leap Therapeutics, Inc.
11-Jun-2020	AVM Biotechnology Awarded SBIR Phase I Grant from National Cancer Institute	AVM Biotechnology, LLC